Zhenyu Ding

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.2K citations · Full text

Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer

You Lü, Jianxin Xue, Tao Deng et al. · Nature Medicine · 2020 · 510 citations

Off-target Effect, Medicine, Immunology +10

Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer

Zhenyu Ding, Qing Li, Rui Zhang et al. · Signal Transduction and Targeted Therapy · 2021 · 254 citations · Full text

DP7-C-modified liposomes enhance immune responses and the antitumor effect of a neoantigen-based mRNA vaccine

Rui Zhang, Lin Tang, Yaomei Tian et al. · Journal of Controlled Release · 2020 · 94 citations

Vaccination, Tumor Immunology, Neoantigen-based Mrna Vaccine +9

A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Patients with Initially Diagnosed Metastatic Esophageal Cancer: A SEER-Based Study

Xin Tang, Xiaojuan Zhou, Yanying Li et al. · Annals of Surgical Oncology · 2018 · 88 citations

Radiology, Esophageal Cancer, Medicine +9